PLIANT THERAPEUTICS, INC. (PLRX)

PLIANT THERAPEUTICS, INC. (PLRX) scores 37 out of 100 on boothcheck's 11-model valuation framework. Verdict: Bad The estimated fair value is $0.00. Quantitative score: 40/100. Qualitative score: 60/100.

Analysis includes bear, base, and bull fair value targets using DCF, Graham, regression, and 8 other valuation models.

View full PLRX analysis on boothcheck